Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000084436 | SCV000779672 | pathogenic | not provided | 2022-02-21 | criteria provided, single submitter | clinical testing | Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); Also reported in an individual with a clinical diagnosis of posterior cortical atrophy with visual deficits, apperceptive visual agnosia, and occipital cortical atrophy (Caroppo et al., 2015); This variant is associated with the following publications: (PMID: 25525159, 29614680, 17698705, 30528841, 28749476, 30279455, 22312439, 25546130) |
Institute of Human Genetics Munich, |
RCV000767861 | SCV000897721 | pathogenic | GRN-related frontotemporal lobar degeneration with Tdp43 inclusions | 2021-01-29 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000084436 | SCV001250430 | pathogenic | not provided | 2023-10-01 | criteria provided, single submitter | clinical testing | GRN: PVS1, PM2 |
Athena Diagnostics | RCV000084436 | SCV001475245 | pathogenic | not provided | 2020-05-11 | criteria provided, single submitter | clinical testing | The variant creates a premature nonsense codon, and is therefore predicted to result in the loss of a functional protein. Found in at least one patient with expected phenotype for this gene, and found in general population data at a frequency that is consistent with pathogenicity. |
New York Genome Center | RCV001291777 | SCV001480394 | pathogenic | Neuronal ceroid lipofuscinosis 11 | 2020-04-24 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001387934 | SCV001588693 | pathogenic | GRN-related frontotemporal lobar degeneration with Tdp43 inclusions; Neuronal ceroid lipofuscinosis 11 | 2022-07-06 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. ClinVar contains an entry for this variant (Variation ID: 98134). This premature translational stop signal has been observed in individual(s) with clinical features of frontotemporal dementia (PMID: 17698705, 22312439, 30528841). This variant is present in population databases (rs63750411, gnomAD 0.0009%). This sequence change creates a premature translational stop signal (p.Arg110*) in the GRN gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in GRN are known to be pathogenic (PMID: 16862116, 16950801, 22608501). |
Clinical Genetics Laboratory, |
RCV000084436 | SCV005198422 | pathogenic | not provided | 2022-05-27 | criteria provided, single submitter | clinical testing | |
VIB Department of Molecular Genetics, |
RCV000084436 | SCV000116572 | not provided | not provided | no assertion provided | not provided |